Treatment.com AI Inc. announced a non-brokered private placement of up to 5,000,000 special warrants at a price of CAD 0.40 per special warrant for aggregate gross proceeds of up to CAD 2,000,000 on February 16, 2024. Each special warrant will automatically convert without payment of any additional consideration into one unit on the date that is the earlier of the third business day after a receipt for a final prospectus or the date of filing a prospectus supplement to a short form base shelf prospectus qualifying the distribution of the shares and warrants issuable upon the conversion of the special warrants, and 4 months and one day after the issue date of the special warrants. Each unit will be comprised of one common share and one-half of one share purchase warrant, with each warrant exercisable into one additional share at an exercise price of CAD 0.60 for two years from the date of closing.

The company may pay a finder's fee of up to 8% of the gross proceeds of the offering and may issue to certain eligible finders non-transferable broker warrants equal up to 8% of the number of special warrants sold under the offering. Each broker warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.60 per broker share for a period of two years from the date of closing. The offering is expected to close on or before February 29, 2024.

The offering is subject to certain conditions including, but not limited to, receipt of all necessary approvals including the approval of the Canadian Securities Exchange. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation.